Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00596
|
|||||
| Drug Name |
Methyldopa
|
|||||
| Synonyms |
(-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate; (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid; (S)-(-)-alpha-Methyldopa; 3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE; 3-Hydroxy-.alpha.-methyl-L-tyrosine; 3-Hydroxy-alpha-methyl-L-tyrosine; AMD; Aldomet; Aldomet (TN); Aldometil; Aldomin; Aldoril (TN); Aldoril D30; Aldoril D50; Aldoril, Dopamet, Dopegyt, Methyldopa; Alpha medopa; Alpha-Methyl dopa; Alpha-Methyl-L-3,4-dihydroxyphenylalanine; Alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine; Alpha-Methyldihydroxyphenylalanine; Alpha-Methyldopa; Alpha-Methyldopa (VAN); Alphamethyldopa; Apo-Methyldopa; Bayer 1440 L; Baypresol; Becanta; Dopamet; Dopamet (TN); Dopamethyperpax; Dopatec; Dopegit; Dopegyt; Dopegyt (TN); Dopergit; Grospisk; Hyperpax; Hypolag; L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine; L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine; L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine; L-(alpha-Md); L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid; L-3-(3,4-Dihydroxyphenyl)-2-methylalanine; L-Methyl Dopa; L-Methyldopa; L-alpha-Methyl DOPA; L-alpha-Methyl-3,4-dihydroxyphenylalanine; L-alpha-Methyldopa; LT00847269; Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine; METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE); MK 351; MK-351; Medomet; Medopa; Medopal; Medopren; Methoplain; Methyl dopa; Methyl-L-dopa; Methyldopa (INN); Methyldopa (L,-); Methyldopa (anhydrous); Methyldopa anhydrous; Methyldopum; Methyldopum [INN-Latin]; Metildopa; Metildopa [INN-Spanish]; Mk. b51; Novomedopa; Nr.C 2294; Nu-Medopa; Presinol; Presolisin; Sedometil; Sembrina
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C10H13NO4
|
|||||
| Canonical SMILES |
CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
|
|||||
| InChI |
InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1
|
|||||
| InChIKey |
CJCSPKMFHVPWAR-JTQLQIEISA-N
|
|||||
| CAS Number |
CAS 555-30-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 211.21 | Topological Polar Surface Area | 104 | ||
| Heavy Atom Count | 15 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
-1.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321684
, 11113581
, 11335317
, 11360556
, 11363831
, 11366393
, 11368955
, 11371621
, 11373686
, 11377117
, 11461528
, 11466354
, 11467474
, 11484792
, 11485988
, 11488884
, 11490317
, 11491869
, 11494751
, 14748911
, 17405414
, 26611818
, 26679555
, 34704829
, 46508535
, 47290999
, 47440113
, 47736324
, 47736325
, 47810607
, 48034965
, 48110315
, 48184859
, 48416254
, 48423673
, 49698436
, 49854436
, 50104474
, 50104475
, 50104476
, 50104477
, 50970645
, 53777959
, 53790662
, 597355
, 7979942
, 8139902
, 8149423
, 8175761
, 9403
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.